CereVasc, Inc.

CereVasc Receives FDA IDE Approval to Evaluate the eShunt® System in Patients with Alzheimer's Disease

FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer's disease Study…